1. Home
  2. CWCO vs ADCT Comparison

CWCO vs ADCT Comparison

Compare CWCO & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consolidated Water Co. Ltd.

CWCO

Consolidated Water Co. Ltd.

HOLD

Current Price

$37.62

Market Cap

599.8M

Sector

Utilities

ML Signal

HOLD

Logo ADC Therapeutics SA

ADCT

ADC Therapeutics SA

HOLD

Current Price

$4.04

Market Cap

484.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CWCO
ADCT
Founded
1973
2011
Country
Cayman Islands
Switzerland
Employees
N/A
N/A
Industry
Water Supply
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
599.8M
484.4M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CWCO
ADCT
Price
$37.62
$4.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$40.00
$7.60
AVG Volume (30 Days)
74.0K
651.6K
Earning Date
03-16-2026
03-26-2026
Dividend Yield
1.50%
N/A
EPS Growth
N/A
N/A
EPS
1.05
N/A
Revenue
$130,832,698.00
$75,209,000.00
Revenue This Year
$5.00
$12.48
Revenue Next Year
$37.71
$5.12
P/E Ratio
$34.44
N/A
Revenue Growth
N/A
6.35
52 Week Low
$22.69
$1.05
52 Week High
$39.12
$4.80

Technical Indicators

Market Signals
Indicator
CWCO
ADCT
Relative Strength Index (RSI) 50.68 60.09
Support Level $36.50 $3.66
Resistance Level $38.74 $4.10
Average True Range (ATR) 1.03 0.26
MACD -0.14 0.03
Stochastic Oscillator 33.90 89.95

Price Performance

Historical Comparison
CWCO
ADCT

About CWCO Consolidated Water Co. Ltd.

Consolidated Water Co Ltd is a water utility company. It develops and operates seawater desalination plants and water distribution systems. The company's business segments are; The retail segment operates the water utility for the Seven Mile Beach and West Bay areas of Grand Cayman Island, The bulk segment supplies potable water to government utilities in Grand Cayman and The Bahamas under long-term contracts, The services segment designs, constructs and sells water infrastructure and provides management and operating services to third parties. The manufacturing segment manufactures and services a wide range of custom and specialized water-related products applicable to commercial, municipal, and industrial water production, supply, and treatment, and the corporate segment.

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

Share on Social Networks: